BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 28497352)

  • 1. Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient.
    Ozen S; Demir S
    Paediatr Drugs; 2017 Aug; 19(4):303-311. PubMed ID: 28497352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoinflammatory Diseases with Periodic Fevers.
    Sag E; Bilginer Y; Ozen S
    Curr Rheumatol Rep; 2017 Jul; 19(7):41. PubMed ID: 28631068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome.
    Ozen S; Kuemmerle-Deschner JB; Cimaz R; Livneh A; Quartier P; Kone-Paut I; Zeft A; Spalding S; Gul A; Hentgen V; Savic S; Foeldvari I; Frenkel J; Cantarini L; Patel D; Weiss J; Marinsek N; Degun R; Lomax KG; Lachmann HJ
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):578-586. PubMed ID: 27723279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hereditary autoinflammatory diseases.
    Ter Haar NM; Frenkel J
    Curr Opin Rheumatol; 2014 May; 26(3):252-8. PubMed ID: 24667287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
    Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodic fever syndromes.
    Lachmann HJ
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):596-609. PubMed ID: 29773275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodic Fever syndromes.
    Wurster VM; Carlucci JG; Edwards KM
    Pediatr Ann; 2011 Jan; 40(1):48-54. PubMed ID: 21210600
    [No Abstract]   [Full Text] [Related]  

  • 8. The Eurofever Project: towards better care for autoinflammatory diseases.
    Ozen S; Frenkel J; Ruperto N; Gattorno M;
    Eur J Pediatr; 2011 Apr; 170(4):445-52. PubMed ID: 21360011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoinflammatory syndromes.
    Hashkes PJ; Toker O
    Pediatr Clin North Am; 2012 Apr; 59(2):447-70. PubMed ID: 22560579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND initiative.
    Hansmann S; Lainka E; Horneff G; Holzinger D; Rieber N; Jansson AF; Rösen-Wolff A; Erbis G; Prelog M; Brunner J; Benseler SM; Kuemmerle-Deschner JB
    Pediatr Rheumatol Online J; 2020 Feb; 18(1):17. PubMed ID: 32066461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hereditary periodical fever syndromes].
    Herlin T; Sørensen N; Veirum J
    Ugeskr Laeger; 2011 Mar; 173(13):968-73. PubMed ID: 21453638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
    N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist.
    Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron KS; Benseler S; Berard R; Broderick L; Dedeoglu F; Diebold M; Durrant KL; Ferguson P; Foell D; Hausmann J; Jones OY; Kastner DL; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman H; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E
    Ann Rheum Dis; 2022 Jul; 81(7):907-921. PubMed ID: 35623638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin-1 Mediated Autoinflammatory Diseases: Cryopyrin-Associated Periodic Syndromes, Tumour Necrosis Factor Receptor-Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin-1 Receptor Antagonist.
    Romano M; Arici ZS; Piskin D; Alehashemi S; Aletaha D; Barron K; Benseler S; Berard RA; Broderick L; Dedeoglu F; Diebold M; Durrant K; Ferguson P; Foell D; Hausmann JS; Jones OY; Kastner D; Lachmann HJ; Laxer RM; Rivera D; Ruperto N; Simon A; Twilt M; Frenkel J; Hoffman HM; de Jesus AA; Kuemmerle-Deschner JB; Ozen S; Gattorno M; Goldbach-Mansky R; Demirkaya E
    Arthritis Rheumatol; 2022 Jul; 74(7):1102-1121. PubMed ID: 35621220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples.
    Oldham J; Lachmann HJ
    Clin Exp Dermatol; 2020 Dec; 45(8):967-973. PubMed ID: 32882069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monogenic Auto-inflammatory Syndromes: A Review of the Literature.
    Azizi G; Khadem Azarian S; Nazeri S; Mosayebian A; Ghiasy S; Sadri G; Mohebi A; Khan Nazer NH; Afraei S; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2016 Dec; 15(6):430-444. PubMed ID: 28129677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG).
    Al-Mayouf SM; Almutairi A; Albrawi S; Fathalla BM; Alzyoud R; AlEnazi A; Abu-Shukair M; Alwahadneh A; Alsonbul A; Zlenti M; Khawaja E; Abushhaiwia A; Khawaja K; AlMosawi Z; Madan W; Almuatiri M; Almuatiri N;
    Rheumatol Int; 2020 Jan; 40(1):49-56. PubMed ID: 31741047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors.
    Milota T; Malcová H; Střížová Z; Cebecauerová D; Horváth R
    Cas Lek Cesk; 2022; 161(1):3-10. PubMed ID: 35354288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases.
    Sözeri B; Demir F; Sönmez HE; Karadağ ŞG; Demirkol YK; Doğan ÖA; Doğanay HL; Ayaz NA
    Clin Rheumatol; 2021 Jun; 40(6):2327-2337. PubMed ID: 33165748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry.
    Kuemmerle-Deschner JB; Kallinich T; Henes J; Kortus-Götze B; Oommen PT; Rech J; Krickau T; Weller-Heinemann F; Horneff G; Janda A; Foeldvari I; Schuetz C; Dressler F; Borte M; Hufnagel M; Meier F; Fiene M; Andreica I; Weber-Arden J; Blank N
    RMD Open; 2024 Feb; 10(1):. PubMed ID: 38360038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.